Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Viking Therapeutics stock
Learn how to easily invest in Viking Therapeutics stock.
Viking Therapeutics Inc is a biotechnology business based in the US. Viking Therapeutics shares (VKTX) are listed on the NASDAQ and all prices are listed in US Dollars. Viking Therapeutics employs 17 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Viking Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – VKTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Viking Therapeutics stock price (NASDAQ: VKTX)Use our graph to track the performance of VKTX stocks over time.
Viking Therapeutics shares at a glance
|Latest market close||$2.72|
|52-week range||$2.02 - $7.05|
|50-day moving average||$3.22|
|200-day moving average||$3.21|
|Wall St. target price||$17.56|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.73|
Buy Viking Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Viking Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Viking Therapeutics price performance over time
|1 week (2022-09-27)||4.62%|
|1 month (2022-09-02)||-14.20%|
|3 months (2022-07-01)||-3.55%|
|6 months (2022-04-04)||-13.65%|
|1 year (2021-10-04)||-55.04%|
|2 years (2020-10-02)||-50.99%|
|3 years (2019-10-04)||6.95|
|5 years (2017-10-04)||43.92%|
Viking Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-17.82%|
|Return on equity TTM||-30.31%|
|Market capitalisation||$213.6 million|
TTM: trailing 12 months
Viking Therapeutics share dividends
We're not expecting Viking Therapeutics to pay a dividend over the next 12 months.
Viking Therapeutics share price volatility
Over the last 12 months, Viking Therapeutics's shares have ranged in value from as little as $2.02 up to $7.045. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Viking Therapeutics's is 1.3504. This would suggest that Viking Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Viking Therapeutics overview
Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California. .
Viking Therapeutics in the news
Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon
Viking Therapeutics to Participate at Upcoming Investor Conferences
Frequently asked questionsWhat percentage of Viking Therapeutics is owned by insiders or institutions?
Currently 11.624% of Viking Therapeutics shares are held by insiders and 35.832% by institutions. How many people work for Viking Therapeutics?
Latest data suggests 17 work at Viking Therapeutics. When does the fiscal year end for Viking Therapeutics?
Viking Therapeutics's fiscal year ends in December. Where is Viking Therapeutics based?
Viking Therapeutics's address is: 9920 Pacific Heights Boulevard, San Diego, CA, United States, 92121 What is Viking Therapeutics's ISIN number?
Viking Therapeutics's international securities identification number is: US92686J1060 What is Viking Therapeutics's CUSIP number?
Viking Therapeutics's Committee on Uniform Securities Identification Procedures number is: 92686J106
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert